1. Home
  2. BRN vs LGVN Comparison

BRN vs LGVN Comparison

Compare BRN & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnwell Industries Inc.

BRN

Barnwell Industries Inc.

BUY

Current Price

$1.10

Market Cap

13.8M

Sector

Energy

ML Signal

BUY

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$0.59

Market Cap

12.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRN
LGVN
Founded
1956
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.8M
12.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BRN
LGVN
Price
$1.10
$0.59
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.50
AVG Volume (30 Days)
143.7K
245.5K
Earning Date
02-13-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,697,000.00
$1,437,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$0.49
52 Week High
$2.28
$1.92

Technical Indicators

Market Signals
Indicator
BRN
LGVN
Relative Strength Index (RSI) 48.39 52.07
Support Level $1.08 $0.56
Resistance Level $1.22 $0.65
Average True Range (ATR) 0.10 0.04
MACD 0.00 0.01
Stochastic Oscillator 17.14 54.20

Price Performance

Historical Comparison
BRN
LGVN

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: